Core Viewpoint - Shenzhen Yingjixin Technology Co., Ltd. (referred to as Yingjixin) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure laws, following misleading statements made on the Shanghai Stock Exchange's E-interaction platform [1][2][4]. Group 1: Investigation Details - On February 13, 2026, Yingjixin received a notice from the CSRC regarding the initiation of an investigation due to suspected violations of information disclosure laws [1][3]. - The CSRC's investigation stems from a January 6, 2026, incident where Yingjixin engaged in a "self-questioning and answering" format on the E-interaction platform, which was deemed to have misled investors [2][4]. - The CSRC has stated that it will conduct a comprehensive investigation and take legal action to maintain market health [2][4]. Group 2: Product and Market Impact - Yingjixin claimed to have entered the brain-computer interface chip sector with its IPA1299 chip, which is an 8-channel, low-noise 24-bit ADC chip designed for high-precision measurement of human bioelectrical signals [5]. - The IPA1299 chip has been mass-produced and is said to have performance parameters comparable to leading overseas chip products; however, the company later clarified that the chip was developed in collaboration with a subsidiary and is still in the market cultivation phase, with no significant sales impact on the company's performance [5][6]. - The company reported a total revenue of 1.612 billion yuan for the fiscal year 2025, representing a year-on-year increase of 12.65%, and a net profit of 177 million yuan, up 42.81% year-on-year [6]. Group 3: Investor Implications - Investors who purchased Yingjixin shares between January 6, 2026, and February 13, 2026, and sold or held them after February 14, 2026, may be eligible for compensation due to the ongoing investigation [6].
英集芯遭证监会立案 投资者或可索赔